查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
氧化壓力化驗的市場規模、佔有率、趨勢分析 (～2030年):各產品、檢驗類型、技術、疾病類型、終端用戶、地區的展望、競爭策略
市場調查報告書
商品編碼
1068143

氧化壓力化驗的市場規模、佔有率、趨勢分析 (～2030年):各產品、檢驗類型、技術、疾病類型、終端用戶、地區的展望、競爭策略

Global Oxidative Stress Assays Market Size, Share & Trends Analysis By Product, By Test Type, By Technology, By Disease Type, By End User, Regional Outlook, Competitive Strategies and Segment Forecasts to 2030
出版日期: | 出版商: SPER Market Research Pvt. Ltd. | 英文 235 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

全球氧化壓力化驗的市場規模在預測期間內預計以8.6％的年複合成長率發展，2030年成長到18億9,800萬美元的規模。慢性疾病和文明病的擴大導致生物醫藥品和生物科技企業的成長，更加推動氧化壓力化驗市場成長。

本報告提供全球氧化壓力化驗的市場調查，市場概要，市場成長的各種影響因素分析，主要趨勢，市場規模的變化、預測，各種區分、各地區的詳細分析，競爭環境，主要企業簡介等彙整資訊。

目錄

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 市場動態

  • 成長要素、阻礙因素、機會、課題的分析
  • COVID-19:氧化壓力化驗對市場的影響

第5章 市場可變因素、展望

  • SWOT分析
  • PESTEL分析
  • 波特的五力分析
  • 熱圖分析

第6章 全球氧化壓力化驗市場:各產品

  • 消耗品
  • 套件
  • 試劑
  • 設備
  • 服務

第7章 全球氧化壓力化驗市場:各檢驗類型

  • 抗氧化能力化驗
  • 抗壞血酸化驗
  • 麩胺基硫化驗
  • 細胞為基礎的外因性抗氧化化驗
  • 間接化驗
  • 脂質為基礎的化驗
  • 核酸為基礎的化驗
  • 蛋白質為基礎的化驗
  • 酵素為基礎的化驗
  • 活性氧為基礎的化驗

第8章 全球氧化壓力化驗市場:各技術

  • 酵素免疫分析法 (ELISA)
  • 流式細胞技術
  • 高內涵篩選 (HCS)
  • 免標定檢測
  • 顯微鏡檢驗
  • 層析法

第9章 全球氧化壓力化驗市場:各疾病類型

  • 循環系統疾病
  • 糖尿病
  • 癌症
  • 呼吸疾病
  • 其他

第10章 全球氧化壓力化驗市場:各終端用戶

  • 臨床實驗室
  • CRO
  • 製藥、生物科技企業
  • 學術研究機關
  • 化妝品企業

第11章 全球氧化壓力化驗市場:各地區

  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東、非洲

第12章 企業簡介

  • Abcam, plc
  • AMS Biotechnology
  • Arbor Assays
  • BioVision, Inc.
  • Callegari SRL
  • Cayman Chemical
  • Cell Biolabs, Inc.
  • Eagle Biosciences, Inc.
  • Enzo Biochem, Inc.
  • Genox Corporation
  • Hycult Biotech
  • ImmunoChemistry Technologies, LLC
  • Kamiya Biomedical Company
  • MEGA TIP San.Tic.Ltd.Sti.
  • Merck KGaA
  • Oxford Biomedical Research
  • Promega Corporation
  • QIAGEN N.V.
  • Thermo Fisher Scientific, Inc.
  • Toxys B.V.
簡介目錄
Product Code: BIOT2212

Global oxidative stress assays market is projected to be worth USD 1898 million by 2030.

According to SPER Market Research, the oxidative stress assays market is estimated to reach USD 1898 million by 2030 with a CAGR of 8.6%. Rising prevalence of chronic and lifestyle disorders has led to the growth of biopharmaceutical and biotechnology companies which is further driving the growth of oxidative stress assays market.

Impact of COVID-19 on the Oxidative Stress Assays Market

COVID-19 has a slightly negative impact on oxidative stress assays market due to economic impact on companies, stringent regulatory process, disruptions in supply chain impacting the research activities. In upcoming years, academic research activities will rise leading to growth of oxidative stress assays market.

Scope of the report:

Market size available for years:

  • Market size available for years: 2019-2030
  • Base year considered: 2021
  • Forecast period: 2022-2030

Segments covered

  • By Product, By Test Type, By Technology, By Disease, By End User

Geographies covered

  • North America, Europe, APAC, Latin America and the Middle East & Africa

Companies Covered

  • Abcam, plc, AMS Biotechnology, Arbor Assays, BioVision, Inc., Callegari SRL, Cayman Chemical, Cell Biolabs, Inc., Eagle Biosciences, Inc., Enzo Biochem, Inc., Genox Corporation, Hycult Biotech, ImmunoChemistry Technologies, LLC, Kamiya Biomedical Company, MEGA TIP San.Tic.Ltd.Sti., Merck KGaA, Oxford Biomedical Research, Promega Corporation, QIAGEN N.V., Thermo Fisher Scientific, Inc., Toxys B.V.

Driver: Rapidly growing biotechnology and biopharmaceutical industries

The biopharmaceutical and biotechnological industries are growing with technological advancements and rising demand. Oxidative stress assays are applied in both biopharmaceutical and biotechnological companies in cell cultures. Growth of these industries can drive the growth of oxidative stress assays market in the forecast period.

Restraints: Highly costly instruments

Advanced technologies for oxidative stress assays such as label-free detection and high-content screening are advantageous with advanced features and functions as compared to conventional technologies. Therefore, such instruments are priced at a premium cost. Companies with limited R&D budgets can not afford these instruments. The pharmaceutical companies require large number of such systems, thus overall cost of ownership combined with maintenance and indirect costs becomes very high. Thus, the cost of these instruments can restrain the growth of this market.

Opportunity: Growth opportunities in emerging economies

Emerging economies such as Russia, China, Brazil, India are offering growth opportunities to oxidative stress assays market. Factor attributing these opportunities is increasing R&D funding and investments for research organizations. Asian countries such as India and China have CROs that provide drug discovery services to pharmaceutical industries. The outsourcing of research work helps in increasing the efficiency in limited time.

Oxidative Stress Assays Market by Product:

Based on product, market has been segmented into Consumables, Kits, Reagents, Instruments, Services

Oxidative Stress Assays Market by Test Type:

Based on test type, the market is segmented into Antioxidant Capacity Assays, Ascorbic Acid Assays, Glutathione Assays, Cell-based Exogenous Antioxidant Assays, Indirect Assays, Lipid-based Assays, Nucleic Acid-based Assays, Protein-based Assays, Enzyme-based Assays, Reactive Oxygen Species-based Assays

Oxidative Stress Assays Market by Technology:

Based on technology, market has been segmented into Enzyme-linked Immunosorbent Assay (ELISA), Flow Cytometry, High-content Screening (HCS), Label-free Detection, Microscopy, Chromatography

Oxidative Stress Assays Market by Disease Type:

Based on disease type, market has been segmented into Cardiovascular Disease, Diabetes, Cancer, Respiratory Diseases, Other Diseases

Cardiovascular Disease segment accounted for largest share due to rising prevalence of cardiovascular diseases and unhealthy lifestyle.

Oxidative Stress Assays Market by End User:

Based on end user, the market is segmented into Clinical Laboratories, Contract Research Organizations, Pharmaceutical and Biotechnology Companies, Academic Research Institutes, Cosmetic Companies

Oxidative Stress Assays Market by Region:

North America owns the largest share of this market owing to advanced healthcare infrastructure, rising investments in healthcare, presence of leading players and technological advancement. However, Asia Pacific will grow at the highest CAGR owing to supportive government initiatives, rising awareness, rising investments and rising income.

Table of Contents

1. Introduction

  • 1.1. Scope of the report
  • 1.2. Market segment analysis

2. Research Methodology

  • 2.1. Research data source
    • 2.1.1. Secondary data
    • 2.1.2. Primary data
    • 2.1.3. SPER's internal database
    • 2.1.4. Premium insight from KOL's
  • 2.2. Market size estimation
    • 2.2.1. Top-down and Bottom-up approach
  • 2.3. Data triangulation

3. Executive Summary

4. Market Dynamics

  • 4.1. Driver, Restraint, Opportunity and Challenges analysis
    • 4.1.1. Drivers
    • 4.1.2. Restraints
    • 4.1.3. Opportunities
    • 4.1.4. Challenges
  • 4.2. COVID-19 Impact of the Oxidative Stress Assays Market

5. Market variables and outlook

  • 5.1. SWOT analysis
    • 5.1.1. Strengths
    • 5.1.2. Weaknesses
    • 5.1.3. Opportunities
    • 5.1.4. Threats
  • 5.2. PESTEL analysis
    • 5.2.1. Political landscape
    • 5.2.2. Economic landscape
    • 5.2.3. Social landscape
    • 5.2.4. Technological landscape
    • 5.2.5. Environmental landscape
    • 5.2.6. Legal landscape
  • 5.3. PORTER'S five forces analysis
    • 5.3.1. Bargaining power of suppliers
    • 5.3.2. Bargaining power of Buyers
    • 5.3.3. Threat of Substitute
    • 5.3.4. Threat of new entrant
    • 5.3.5. Competitive rivalry
  • 5.4. Heat map analysis

6. Global Oxidative Stress Assays Market, By Product, 2019-2030 (USD Million)

  • 6.1. Consumables
  • 6.2. Kits
  • 6.3. Reagents
  • 6.4. Instruments
  • 6.5. Services

7. Global Oxidative Stress Assays Market, By Test Type, 2019-2030 (USD Million)

  • 7.1. Antioxidant Capacity Assays
  • 7.2. Ascorbic Acid Assays
  • 7.3. Glutathione Assays
  • 7.4. Cell-based Exogenous Antioxidant Assays
  • 7.5. Indirect Assays
  • 7.6. Lipid-based Assays
  • 7.7. Nucleic Acid-based Assays
  • 7.8. Protein-based Assays
  • 7.9. Enzyme-based Assays
  • 7.10. Reactive Oxygen Species-based Assays

8. Global Oxidative Stress Assays Market, By Technology, 2019-2030 (USD Million)

  • 8.1. Enzyme-linked Immunosorbent Assay (ELISA)
  • 8.2. Flow Cytometry
  • 8.3. High-content Screening (HCS)
  • 8.4. Label-free Detection
  • 8.5. Microscopy
  • 8.6. Chromatography

9. Global Oxidative Stress Assays Market, By Disease Type, 2019-2030 (USD Million)

  • 9.1. Cardiovascular Disease
  • 9.2. Diabetes
  • 9.3. Cancer
  • 9.4. Respiratory Diseases
  • 9.5. Other Diseases

10. Global Oxidative Stress Assays Market, By End User, 2019-2030 (USD Million)

  • 10.1. Clinical Laboratories
  • 10.2. Contract Research Organizations
  • 10.3. Pharmaceutical and Biotechnology Companies
  • 10.4. Academic Research Institutes
  • 10.5. Cosmetic Companies

11. Global Oxidative Stress Assays Market, By Region, 2019-2030 (USD Million)

  • 11.1. North America
    • 11.1.1. United States
    • 11.1.2. Canada
    • 11.1.3. Mexico
  • 11.2. Europe
    • 11.2.1. Germany
    • 11.2.2. United Kingdom
    • 11.2.3. France
    • 11.2.4. Italy
    • 11.2.5. Spain
    • 11.2.6. Rest of Europe
  • 11.3. Asia-Pacific
    • 11.3.1. China
    • 11.3.2. Japan
    • 11.3.3. India
    • 11.3.4. Australia
    • 11.3.5. South Korea
    • 11.3.6. Rest of Asia-Pacific
  • 11.4. South America
    • 11.4.1. Brazil
    • 11.4.2. Argentina
    • 11.4.3. Rest of South America
  • 11.5. Middle East & Africa
    • 11.5.1. Kingdom of Saudi Arabia
    • 11.5.2. United Arab Emirates
    • 11.5.3. Rest of Middle East & Africa

12. Company Profiles

  • 12.1. Abcam, plc
    • 12.1.1. Company details
    • 12.1.2. Financial outlook
    • 12.1.3. Product summary
    • 12.1.4. Recent developments
  • 12.2. AMS Biotechnology
    • 12.2.1. Company details
    • 12.2.2. Financial outlook
    • 12.2.3. Product summary
    • 12.2.4. Recent developments
  • 12.3. Arbor Assays
    • 12.3.1. Company details
    • 12.3.2. Financial outlook
    • 12.3.3. Product summary
    • 12.3.4. Recent developments
  • 12.4. BioVision, Inc.
    • 12.4.1. Company details
    • 12.4.2. Financial outlook
    • 12.4.3. Product summary
    • 12.4.4. Recent developments
  • 12.5. Callegari SRL
    • 12.5.1. Company details
    • 12.5.2. Financial outlook
    • 12.5.3. Product summary
    • 12.5.4. Recent developments
  • 12.6. Cayman Chemical
    • 12.6.1. Company details
    • 12.6.2. Financial outlook
    • 12.6.3. Product summary
    • 12.6.4. Recent developments
  • 12.7. Cell Biolabs, Inc.
    • 12.7.1. Company details
    • 12.7.2. Financial outlook
    • 12.7.3. Product summary
    • 12.7.4. Recent developments
  • 12.8. Eagle Biosciences, Inc.
    • 12.8.1. Company details
    • 12.8.2. Financial outlook
    • 12.8.3. Product summary
    • 12.8.4. Recent developments
  • 12.9. Enzo Biochem, Inc.
    • 12.9.1. Company details
    • 12.9.2. Financial outlook
    • 12.9.3. Product summary
    • 12.9.4. Recent developments
  • 12.10. Genox Corporation
    • 12.10.1. Company details
    • 12.10.2. Financial outlook
    • 12.10.3. Product summary
    • 12.10.4. Recent developments
  • 12.11. Hycult Biotech
    • 12.11.1. Company details
    • 12.11.2. Financial outlook
    • 12.11.3. Product summary
    • 12.11.4. Recent developments
  • 12.12. ImmunoChemistry Technologies, LLC
    • 12.12.1. Company details
    • 12.12.2. Financial outlook
    • 12.12.3. Product summary
    • 12.12.4. Recent developments
  • 12.13. Kamiya Biomedical Company
    • 12.13.1. Company details
    • 12.13.2. Financial outlook
    • 12.13.3. Product summary
    • 12.13.4. Recent developments
  • 12.14. MEGA TIP San.Tic.Ltd.Sti.
    • 12.14.1. Company details
    • 12.14.2. Financial outlook
    • 12.14.3. Product summary
    • 12.14.4. Recent developments
  • 12.15. Merck KGaA
    • 12.15.1. Company details
    • 12.15.2. Financial outlook
    • 12.15.3. Product summary
    • 12.15.4. Recent developments
  • 12.16. Oxford Biomedical Research
    • 12.16.1. Company details
    • 12.16.2. Financial outlook
    • 12.16.3. Product summary
    • 12.16.4. Recent developments
  • 12.17. Promega Corporation
    • 12.17.1. Company details
    • 12.17.2. Financial outlook
    • 12.17.3. Product summary
    • 12.17.4. Recent developments
  • 12.18. QIAGEN N.V.
    • 12.18.1. Company details
    • 12.18.2. Financial outlook
    • 12.18.3. Product summary
    • 12.18.4. Recent developments
  • 12.19. Thermo Fisher Scientific, Inc.
    • 12.19.1. Company details
    • 12.19.2. Financial outlook
    • 12.19.3. Product summary
    • 12.19.4. Recent developments
  • 12.20. Toxys B.V.
    • 12.20.1. Company details
    • 12.20.2. Financial outlook
    • 12.20.3. Product summary
    • 12.20.4. Recent developments